- Home
- CLNN vs ASPS Comparison
CLNN vs ASPS Comparison
Compare CLNN & ASPS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CLNN | ASPS |
|---|---|---|
| Founded | 2012 | 1999 |
| Country | United States | Luxembourg |
| Employees | 79 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Other Consumer Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 85.7M | 70.7M |
| IPO Year | N/A | 2025 |
Fundamental Metrics
Financial Performance| Metric | CLNN | ASPS |
|---|---|---|
| Price | $6.18 | $6.82 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 4 | 1 |
| Target Price | ★ $33.75 | $8.00 |
| AVG Volume (30 Days) | ★ 93.4K | 12.0K |
| Earning Date | 05-08-2026 | 04-23-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 112.00 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $942,213,000.00 |
| Revenue This Year | $17.64 | $9.17 |
| Revenue Next Year | $19,516.77 | $24.26 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $3.25 | $4.30 |
| 52 Week High | $13.50 | $15.96 |
Technical Indicators
Market Signals| Indicator | CLNN | ASPS |
|---|---|---|
| Relative Strength Index (RSI) | 51.94 | 63.03 |
| Support Level | $5.46 | $6.02 |
| Resistance Level | $6.71 | $7.35 |
| Average True Range (ATR) | 0.38 | 0.27 |
| MACD | 0.05 | 0.08 |
| Stochastic Oscillator | 74.38 | 100.00 |
Price Performance
Historical ComparisonAbout CLNN Clene Inc.
Clene Inc is a clinical-stage pharmaceutical company pioneering the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. It is focused on the development of therapeutics for neurodegenerative diseases. It developed an electro-crystal-chemistry drug development platform that enables the production of concentrated, stable, clean-surfaced nanocrystal suspensions. It operates in one segment the development and commercialization of dietary supplements (Supplements). Products includes CNM-Au8, CNM-ZnA, CNM-AgZn17, rMetx, KHC46.
About ASPS Altisource Portfolio Solutions S.A.
Altisource Portfolio Solutions SA is an integrated service provider and marketplace for the real estate and mortgage industries. It operates via two reportable segments, namely Servicer and Real Estate, which derive maximum revenue, and Origination. The Servicer and Real Estate segment provides loan servicers and real estate investors with solutions and technologies that span the mortgage and real estate lifecycle. The Origination segment provides originators with solutions and technologies that span the mortgage origination lifecycle. Altisource mainly serves financial institutions, government-sponsored enterprises, and originators in the United States, with the majority of its revenue flowing from field services and mortgage and real estate solutions.